Clopidogrel in Infants With Systemic-to-Pulmonary-Artery Shunts

Study Questions:

Does the addition of clopidogrel to standard therapy reduce all-cause mortality and shunt-related morbidity in infants with cyanotic congenital heart disease palliated with systemic-to-pulmonary-artery shunts?